Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study

BACKGROUND: Antipsychotic (AP) polypharmacy (APP), the coprescription of more than 1 AP, is frequently practiced in psychiatric inpatients and is considered to be a risk factor for adverse drug events (ADEs). However, the association between APP and ADEs among psychiatric inpatients has not been wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayani, Nobutaka, Morimoto, Takeshi, Sakuma, Mio, Kikuchi, Toshiaki, Watanabe, Koichiro, Narumoto, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244930/
https://www.ncbi.nlm.nih.gov/pubmed/34108429
http://dx.doi.org/10.1097/JCP.0000000000001416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244930/
https://www.ncbi.nlm.nih.gov/pubmed/34108429
http://dx.doi.org/10.1097/JCP.0000000000001416

Ejemplares similares